—

Alkermes Plc(ALKS)— 同業公司組

數據截至2026-10-09 — 評分每個交易日晚間重新計算。分組標準=首先為共同的Closelook指數成分,其次為產業。Closelook研究日記,不構成投資建議。

Alkermes Plc的Closelook綜合評分為51/100,在同業公司組內排名第11位(共11家)——組內評分最高的是Halozyme Therapeutics Inc(74/100)。

名稱綜合動能品質估值訊號距52週高點
ALKS Alkermes Plc51505125info27.1%
LNTH Lantheus Holdings Inc59687257info10.5%
KNSA Kiniksa Pharmaceuticals Ltd56945721ok3.8%
BHC.TO Bausch Health Companies Inc55657084info22%
AMRX Amneal Pharmaceuticals, Inc. Class A Common Stock54895642ok6%
GALDY GALDERMA GROUP AG54455727info14.1%
ALM.MC Almirall S.A.53224469warn26.9%
HALO Halozyme Therapeutics Inc74939451ok5.5%
DXCM DexCom Inc66818038watch8.8%
ONC BeiGene, Ltd.63776232info8%
MEDP Medpace Holdings Inc63847430ok9.7%

評分為Closelook全部涵蓋範圍內的相對讀數——方法論詳見公司評分說明。訊號燈來自每日夜間訊號看板。

FAQ · from the current data · as of 2026-10-09

Quick answers

Alkermes Plc在Closelook涵蓋範圍內的同業公司有哪些?

分組首先根據共同的Closelook指數成分,其次根據產業:Lantheus Holdings Inc (LNTH)、Kiniksa Pharmaceuticals Ltd (KNSA)、Bausch Health Companies Inc (BHC.TO)、Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX)、GALDERMA GROUP AG (GALDY)、Almirall S.A. (ALM.MC)、Halozyme Therapeutics Inc (HALO)、DexCom Inc (DXCM)等。

ALKS相對同業公司的評分如何?

Alkermes Plc的綜合評分為51/100,組內排名第11位(共11家),截至2026-10-09;組內最高綜合評分為Halozyme Therapeutics Inc(74/100)。Closelook評分為研究日記讀數,不構成評等或投資建議。

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic, then Healthcare. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.